Success Story: NAILG Obtains NIW Approval for Physician Strengthening National Efforts in Addiction Research and Treatment
On October 31st, 2025, we received another EB-2 NIW (National Interest Waiver) approval for an Internal Medicine Resident in the field of Substance Use Disorder (Approval Notice).
General Field: Substance Use Disorder
Position at the Time of Case Filing: Internal Medicine Resident
Country of Origin: China
State of Residence at the Time of Filing: Maryland
Approval Notice Date: October 31st, 2025
Processing Time: 1 month, 27 days (Premium Processing Requested)
Case Summary:
As the United States continues to confront the public health and social challenges posed by substance use disorders (SUDs), one physician’s work is helping bridge the gap between clinical care and data-driven public health policy. With the assistance of North America Immigration Law Group (NAILG), this physician obtained EB-2 NIW (National Interest Waiver) approval on October 31, 2025, in just 1 month and 27 days under premium processing. The rapid approval reflects both the strength of the petitioner’s qualifications and NAILG’s strategic legal approach in demonstrating the substantial national importance of the case.
At the time of filing, the petitioner was serving as an Internal Medicine Resident in Maryland, conducting research focused on improving the understanding and management of substance use disorders through population-based data analysis. The proposed endeavor seeks to evaluate treatment outcomes, disparities, and the broader public health impact of addiction, providing evidence that supports more effective healthcare delivery and policy interventions.
The petitioner’s research record includes five peer-reviewed journal articles and one conference abstract, collectively cited 65 times by independent researchers. These studies examine the epidemiology and treatment of addiction across diverse populations, advancing the national conversation on the prevention and treatment of opioid and alcohol use disorders. By leveraging real-world data, the petitioner’s work identifies crucial factors influencing treatment success and recovery, guiding policymakers and healthcare providers toward equitable and evidence-based solutions.
In addition to producing impactful research, the petitioner’s efforts align closely with key national initiatives that emphasize data integration and precision healthcare approaches. The findings contribute directly to national priorities for reducing addiction-related mortality and promoting recovery-focused care.
Through NAILG’s targeted legal strategy, the case effectively demonstrated how the petitioner’s work satisfies the Matter of Dhanasar framework, showing not only substantial merit and national importance but also a proven capacity to continue contributing independently in the United States.
With the NIW approval granted, the petitioner is positioned to continue advancing research that informs addiction prevention, optimizes treatment programs, and supports health equity. This outcome highlights both the petitioner’s dedication to addressing a critical national health issue and NAILG’s continued success in representing professionals whose research and service improve lives across the nation.